BDH Industries Limited is engaged in the manufacturing of pharmaceuticals. The Company is also involved in the manufacturing of therapeutic formulations covering a range of pharmaceuticals. Its segments include Pharmaceuticals, and Renewable Energy. The Company is also engaged in the operations of renewable energy, by way of two wind turbines having capacity of 0.8 megawatts (MW) each located at Jaisalmer, Rajasthan. Its products include Analgesics, Antacids, Antibacterial, Anticoagulants, Anticonvulsants, Antifungals, Antihelmentinics, Antiasthmatic, Antimalarials, Antipsychotics and others. Its products include formulations, such as Fentanyl Citrate Injection USP, KALPANJAN Forte Pain Balm, Compound Magnesium Trisilicate Tablets BP, Alcoholic Iodine Solition BP, COLD Syrup, Dicyclomine Hydrochloride Injection, and Aciclovir Cream BP. Its specialty formulations include Morphine Sulphate Slow-Release Tablets 15mg, Sulfasalazine Delayed release tablets U.S.P. 500mg, and others.As of 26 May 2026, BDH INDUSTRIES LTD. share price is ₹358.15. The stock opened at ₹364.95, compared to its previous close of ₹360.00. During today's trading session, BDH INDUSTRIES LTD. share price moved in the range of ₹357.90 to ₹376.80, with an average price of ₹367.35 for the day. Looking at its last 52-week, the stock has touched a low of ₹357.90 and a high of ₹376.80.
The market capitalization of BDH INDUSTRIES LTD. is ₹206 Crs, with a P/E ratio of 19.2 and a dividend yield of 1.40%.